Success of monoclonal antibody in cancer treatment is now evident in multiple cancers including bladder cancer, sarcoma, colorectal cancer and breast cancer to name a few, targeting different proteins including those of B7-family PD-1 and PD-L1 (138). The gene discussed is CD80; the disease is cancer.